— Know what they know.
Not Investment Advice

OCGN NASDAQ

Ocugen, Inc.
1W: +0.0% 1M: -22.7% 3M: -31.5% YTD: -26.1% 1Y: -39.3% 3Y: +150.8% 5Y: -86.5%
$1.02
+0.02 (+2.00%)
 
Weekly Expected Move ±12.1%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $345.9M mcap · 316M float · 2.16% daily turnover · Short 63% of daily vol

Balance Sheet Trends

Total Assets
$44M -47.2% ▼
5Y CAGR: +9.7%
Total Liabilities
$56M +6.9% ▲
5Y CAGR: +57.5%
Shareholders Equity
-$12M -141.1% ▼
Cash & Investments
$19M -68.3% ▼
5Y CAGR: -5.0%
Total Debt
$33M +2.0% ▲
5Y CAGR: +67.8%
Net Debt
$15M +156.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$95M$78M$39M$59M$19M
Short-Term Investments$0$13M$0$0$0
Cash & ST Investments$95M$91M$39M$59M$19M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$8M$4M$3M$6M
Total Current Assets$103M$98M$43M$62M$24M
Property, Plant & Equip.$1M$6M$17M$17M$14M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$316K
Other Non-Current Assets$2M$4M$4M$4M$4M
Total Non-Current Assets$3M$10M$22M$21M$19M
Total Assets$106M$109M$65M$82M$44M
— Liabilities —
Accounts Payable$2M$8M$3M$4M$6M
Short-Term Debt$0$0$0$1M$1M
Deferred Revenue$0$11M$11M$8M$6M
Other Current Liabilities$2M$3M$1M$5M$6M
Total Current Liabilities$7M$29M$17M$22M$23M
Long-Term Debt$2M$2M$3M$27M$28M
Other Non-Current Liab.$0$244K$527K$564K$2M
Total Non-Current Liabilities$3M$6M$7M$31M$33M
Total Liabilities$10M$35M$24M$53M$56M
— Equity —
Common Stock$2M$2M$3M$3M$3M
Retained Earnings-$132M-$223M-$286M-$340M-$408M
Accumulated OCI$0$26K$20K$48K$61K
Total Stockholders Equity$96M$74M$41M$30M-$12M
Total Liabilities & Equity$106M$109M$65M$82M$44M
— Key Metrics —
Total Debt$3M$6M$7M$33M$33M
Net Debt-$92M-$71M-$33M-$26M$15M
Total Investments$0$13M$0$0$316K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms